Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Drug design Stories

2014-03-25 23:25:20

In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. http://www.marketsandmarkets.com/Market-Reports/latin-american-bioinformatics-market-2908323.html (PRWEB) March 25, 2014 The “Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) &...

2014-02-13 12:27:40

MILLBROOK, N.Y., Feb. 13, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Adam J. Stein, Ph.D. to its Scientific Advisory Committee. Dr. Stein has over eighteen years of experience in structural biology, with the last seven in applying structural biology and biophysical chemistry to the drug discovery efforts in biotech. While at deCODE Genetics, he was able to design fragment libraries that enabled us to elucidate...

2013-12-18 11:38:03

If scientists can control cellular functions such as movement and development, they can cripple cells and pathogens that are causing disease in the body. Supported by National Institutes of Health grants, researchers at Oak Ridge National Laboratory (ORNL), the University of Tennessee (UT), and the UT–ORNL Joint Institute for Computational Sciences (JICS) discovered a molecular “switch” in a receptor that controls cell behavior using detailed molecular dynamics simulations on a...

2013-11-19 23:03:33

Reportbuyer.com just published a new market research report: Orphan Drugs in Oncology Drug Pipeline Update 2013. London (PRWEB) November 19, 2013 This is a worldwide report on cancer drugs which have now or in the past received orphan drug status. This product will give you unique access not only to those cancer indications in which drugs are being granted orphan drug status, but also detailed insights in to their mechanism of action and developmental strategy. The orphan drug designation...

2013-07-17 23:18:46

FileTek, Inc., a leading global provider of large-scale data management, Big Data Storage virtualization, and active archive solutions, today announced that Schrödinger, L.L.C., a scientific leader in computational drug design for pharmaceutical and biotechnology research, has evaluated and selected a StorHouse active archive system to be installed at its Portland, Oregon location. Schrödinger will use StorHouse to secure, protect, back up, and provide access to vital research...

2013-07-05 11:21:49

Researchers at Karolinska Institutet in Sweden have developed the first method for directly measuring the extent to which drugs reach their targets in the cell. The method, which is described in the scientific journal Science, could make a significant contribution to the development of new, improved drug substances. Most drugs operate by binding to one or more proteins and affecting their function, which creates two common bottlenecks in the development of drugs; identifying the right...

2013-07-02 23:04:45

Research report “Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) – Global Forecasts to 2017” prepared by MarketsandMarkets has been recently published by Market Publishers Ltd. London, UK (PRWEB) July 02, 2013 In 2012, the worldwide bioinformatics market was worth above USD 2.87 billion. North...

2013-06-05 12:31:49

New report monitors emerging drug delivery technologies at 62 younger, emerging companies PLUS it's not too late to register for the Structure-Based Drug Design conference FARMINGTON, Conn., June 5, 2013 /PRNewswire-iReach/ -- From Global Information and MCD Group, a new report "Early Stage Drug Delivery Technologies" profiles 62 start-ups and small companies that have interest in forming new partnerships or receiving funding to enable further development and eventual...

2013-04-19 17:57:03

-This is the first study that studies and quantifies 1,600 known adverse effects of drugs currently on the market. -The scientists Miquel Duran and Patrick Aloy provide a description of the molecular processes responsible for more than 1,000 secondary effects. -This knowledge, which is available to the scientific community, may be of great use to minimize and predict adverse effects during drug design. Yellow vision, pseudo-pulmonary obstruction, involuntary body movements, respiratory...

2013-03-07 04:24:08

SAN DIEGO, March 7, 2013 /PRNewswire/ -- Receptos, a biopharmaceutical company focused on developing therapeutic candidates directed to G-protein-coupled receptor (GPCR) targets, announced today that it has successfully determined a novel protein crystal structure of an undisclosed proprietary GPCR drug discovery target for Ono Pharmaceuticals. In December 2011, Ono entered into a technology collaboration to access Receptos' proprietary GPCR structure determination technology platform,...